9th Nov 2021 16:29
(Alliance News) - Renalytix PLC on Tuesday announced a partnership with St Joseph's Health to implement an advanced clinical care model aimed at improving kidney health.
The Cardiff, Wales-based provider of clinical diagnostics for kidney disease, will integrate its KidneyIntelX platform into St Joseph's Health care management system to help patients with diabetes and early-stage kidney disease.
Renalytix outlined that its KidneyIntelX platform is designed to enable physicians to easily understand and implement medication management, nutrition and education intervention protocols on a timely basis.
St Joseph's is part of Trinity Health, a catholic health care delivery system in the US.
"St Joseph's Health shares our forward-thinking, patient-centric approach to changing the standard of care in kidney health. St Joseph's Health's early-stage chronic kidney disease care model, powered by KidneyIntelX, is expected to drive improved clinical and cost outcomes to make healthier kidneys both attainable and sustainable," said Vice President of Commercial Partnerships at Renalytix, Christine Loftsgaarden, .
"This partnership with Renalytix is motivated by our common desire to expand our value proposition to larger populations and further strengthen our population health management capabilities," added Paul Fiacco, MD Medical Director at Trinity Health Integrated Care ACO.
Renalytix shares were down 0.6% at 844.89 pence on Tuesday afternoon in London.
By Abby Amoakuh; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Renalytix Plc